Natixis Advisors LLC increased its position in shares of Humana Inc. (NYSE:HUM – Free Report) by 3.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 57,656 shares of the insurance provider’s stock after buying an additional 2,033 shares during the period. Natixis Advisors LLC’s holdings in Humana were worth $14,767,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also added to or reduced their stakes in the company. Sound View Wealth Advisors Group LLC raised its position in shares of Humana by 3.5% in the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,060 shares of the insurance provider’s stock valued at $272,000 after purchasing an additional 36 shares during the period. CoreCap Advisors LLC lifted its stake in shares of Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after buying an additional 37 shares during the last quarter. Insigneo Advisory Services LLC lifted its stake in shares of Humana by 3.0% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,484 shares of the insurance provider’s stock worth $386,000 after buying an additional 43 shares during the last quarter. Columbus Macro LLC lifted its stake in shares of Humana by 5.5% during the 4th quarter. Columbus Macro LLC now owns 821 shares of the insurance provider’s stock worth $210,000 after buying an additional 43 shares during the last quarter. Finally, Synovus Financial Corp lifted its stake in shares of Humana by 2.0% during the 3rd quarter. Synovus Financial Corp now owns 2,278 shares of the insurance provider’s stock worth $593,000 after buying an additional 45 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of analysts have recently issued reports on the stock. JPMorgan Chase & Co. raised their target price on shares of Humana from $180.00 to $214.00 and gave the stock a “neutral” rating in a research note on Friday, May 1st. Sanford C. Bernstein restated an “outperform” rating and set a $425.00 target price on shares of Humana in a research note on Wednesday. UBS Group raised their target price on shares of Humana from $262.00 to $320.00 and gave the stock a “neutral” rating in a research note on Friday, May 22nd. Weiss Ratings restated a “sell (d+)” rating on shares of Humana in a research note on Tuesday, April 21st. Finally, Jefferies Financial Group upgraded shares of Humana from a “buy” rating to a “buy” rating in a research note on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, fourteen have assigned a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat, Humana presently has an average rating of “Hold” and an average target price of $279.30.
Humana Trading Up 0.0%
Shares of Humana stock opened at $349.85 on Friday. The company has a market capitalization of $42.00 billion, a price-to-earnings ratio of 37.42, a PEG ratio of 2.00 and a beta of 0.76. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $351.88. The firm’s 50-day moving average price is $248.43 and its two-hundred day moving average price is $232.40.
Humana (NYSE:HUM – Get Free Report) last announced its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. The firm had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business’s revenue for the quarter was up 23.5% on a year-over-year basis. During the same period in the prior year, the company posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. On average, analysts forecast that Humana Inc. will post 9 earnings per share for the current fiscal year.
Humana Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio is presently 37.86%.
Humana Company Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Stories
- Five stocks we like better than Humana
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
